Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-07-000013
Filing Date
2007-03-27
Accepted
2007-03-27 16:54:55
Documents
13
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 form10_k.htm 10-K 1932793
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC ballotx.jpg GRAPHIC 762
4 ex4-5.htm EX-4 70327
5 ex9-6.htm EX-9 70009
6 ex10-44.htm EX-10 9583
7 ex10-45.htm EX-10 8061
8 ex10-46.htm EX-10 9635
9 ex23-1.htm EX-23 3076
10 ex31-1.htm EX-31 13723
11 ex31-2.htm EX-31 13727
12 ex32-1.htm EX-32 4487
13 ex32-2.htm EX-32 4625
  Complete submission text file 0001367644-07-000013.txt   2143816
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 07721846
SIC: 2834 Pharmaceutical Preparations